loading
Schlusskurs vom Vortag:
$0.659
Offen:
$0.663
24-Stunden-Volumen:
196.04K
Relative Volume:
0.32
Marktkapitalisierung:
$31.73M
Einnahmen:
$19.94M
Nettoeinkommen (Verlust:
$-37.37M
KGV:
-0.6285
EPS:
-1.04
Netto-Cashflow:
$-33.38M
1W Leistung:
+6.76%
1M Leistung:
+14.39%
6M Leistung:
-51.59%
1J Leistung:
-56.72%
1-Tages-Spanne:
Value
$0.63
$0.6811
1-Wochen-Bereich:
Value
$0.61
$0.7442
52-Wochen-Spanne:
Value
$0.5301
$2.38

Werewolf Therapeutics Inc Stock (HOWL) Company Profile

Name
Firmenname
Werewolf Therapeutics Inc
Name
Telefon
617-952-0555
Name
Adresse
200 TALCOTT AVENUE, WATERTOWN
Name
Mitarbeiter
39
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
HOWL's Discussions on Twitter

Compare HOWL vs VRTX, REGN, ARGX, ALNY, ONC

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
HOWL
Werewolf Therapeutics Inc
0.6536 31.99M 19.94M -37.37M -33.38M -1.04
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
491.47 117.98B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
803.17 82.85B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
821.96 51.58B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
314.40 40.75B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ONC
Beone Medicines Ltd Adr
346.07 38.33B 4.98B 69.60M 525.67M 0.5198

Werewolf Therapeutics Inc Stock (HOWL) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-12-19 Herabstufung Wedbush Outperform → Neutral
2024-04-03 Eingeleitet JMP Securities Mkt Outperform
2023-08-24 Eingeleitet Wedbush Outperform
2023-06-06 Fortgesetzt Jefferies Buy
2021-09-10 Eingeleitet BofA Securities Buy
2021-05-25 Eingeleitet Evercore ISI Outperform
2021-05-25 Eingeleitet H.C. Wainwright Buy
2021-05-25 Eingeleitet Jefferies Buy
2021-05-25 Eingeleitet SVB Leerink Outperform
Alle ansehen

Werewolf Therapeutics Inc Aktie (HOWL) Neueste Nachrichten

pulisher
Feb 13, 2026

Werewolf Therapeutics stock rises over 5% after hours on workforce reduction, including executives - MSN

Feb 13, 2026
pulisher
Feb 13, 2026

Werewolf Therapeutics Stock Rises Over 5% After Hours On Workforce Reduction, Including Executives - Asianet Newsable

Feb 13, 2026
pulisher
Feb 13, 2026

Werewolf Therapeutics Announces Major Workforce and Leadership Restructuring - TipRanks

Feb 13, 2026
pulisher
Feb 13, 2026

Werewolf Therapeutics stock falls after announcing 64% workforce reduction - Investing.com UK

Feb 13, 2026
pulisher
Feb 13, 2026

What insider trading reveals about Werewolf Therapeutics Inc. stockMarket Rally & Scalable Portfolio Growth Ideas - mfd.ru

Feb 13, 2026
pulisher
Feb 12, 2026

What is the target price for Werewolf Therapeutics Inc. stock2025 AllTime Highs & Risk Controlled Stock Pick Alerts - mfd.ru

Feb 12, 2026
pulisher
Feb 11, 2026

Is Werewolf Therapeutics Inc. impacted by rising ratesWeekly Investment Report & Safe Capital Investment Plans - mfd.ru

Feb 11, 2026
pulisher
Feb 11, 2026

Aug Opening: Should I invest in Standard BioTools Inc before earningsWall Street Watch & AI Powered Market Trend Analysis - baoquankhu1.vn

Feb 11, 2026
pulisher
Feb 11, 2026

Does Werewolf Therapeutics Inc. have strong EBITDA marginsJuly 2025 Final Week & Daily Stock Trend Watchlist - mfd.ru

Feb 11, 2026
pulisher
Feb 10, 2026

Aug Ideas: Is now the right time to enter Werewolf Therapeutics Inc2025 Investor Takeaways & Capital Protection Trading Alerts - baoquankhu1.vn

Feb 10, 2026
pulisher
Feb 09, 2026

Death Cross: Is now the right time to enter Werewolf Therapeutics Inc2025 Geopolitical Influence & Consistent Income Trade Ideas - baoquankhu1.vn

Feb 09, 2026
pulisher
Feb 08, 2026

Risk Off: What is the target price for Custom Truck One Source Inc stock2025 EndofYear Setup & Safe Investment Capital Preservation Plans - baoquankhu1.vn

Feb 08, 2026
pulisher
Feb 07, 2026

Werewolf Therapeutics (HOWL) upgraded to buy: Here's what you should know - MSN

Feb 07, 2026
pulisher
Feb 07, 2026

Trading Action: Does Werewolf Therapeutics Inc have strong EBITDA marginsJuly 2025 Momentum & AI Driven Stock Price Forecasts - baoquankhu1.vn

Feb 07, 2026
pulisher
Feb 06, 2026

Werewolf Therapeutics receives Nasdaq notice for minimum bid price deficiency - Investing.com Nigeria

Feb 06, 2026
pulisher
Feb 06, 2026

Werewolf Therapeutics Receives Nasdaq Minimum Bid Price Notice - TipRanks

Feb 06, 2026
pulisher
Feb 06, 2026

Werewolf Therapeutics Received Notice of Noncompliance - TradingView

Feb 06, 2026
pulisher
Feb 03, 2026

Bond Watch: What dividend growth rate does ZENA offerInsider Buying & Weekly Momentum Stock Picks - baoquankhu1.vn

Feb 03, 2026
pulisher
Feb 02, 2026

Is Werewolf Therapeutics Inc stock trending bullish2025 Market Sentiment & Free Verified High Yield Trade Plans - baoquankhu1.vn

Feb 02, 2026
pulisher
Jan 21, 2026

Evnin Luke, Werewolf Therapeutics director, sells $20,942 in Howl stock By Investing.com - Investing.com Australia

Jan 21, 2026
pulisher
Jan 20, 2026

Evnin Luke, Werewolf Therapeutics director, sells $20,942 in Howl stock - Investing.com

Jan 20, 2026
pulisher
Jan 19, 2026

Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Short Interest Update - Defense World

Jan 19, 2026
pulisher
Jan 17, 2026

Movement Recap: Can Black Hawk Acquisition Corporation ride the EV waveGlobal Markets & Growth Focused Entry Point Reports - baoquankhu1.vn

Jan 17, 2026
pulisher
Jan 16, 2026

Werewolf Therapeutics (HOWL) price target decreased by 10.86% to 5.30 - MSN

Jan 16, 2026
pulisher
Jan 16, 2026

Evenin Luke sells Werewolf Therapeutics (HOWL) stock for $61k By Investing.com - Investing.com India

Jan 16, 2026
pulisher
Jan 15, 2026

Evenin Luke sells Werewolf Therapeutics (HOWL) stock for $61k - Investing.com

Jan 15, 2026
pulisher
Jan 14, 2026

Luke Evnin Sells 24,678 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock - Defense World

Jan 14, 2026
pulisher
Jan 13, 2026

Growth Value: Can Werewolf Therapeutics Inc stock double in next 5 yearsPortfolio Performance Report & Expert Curated Trade Setup Alerts - Bộ Nội Vụ

Jan 13, 2026
pulisher
Jan 13, 2026

Werewolf Therapeutics (HOWL) Eyes 2026 Catalysts Following FDA Guidance and Encouraging INDUKINE Results - Yahoo Finance

Jan 13, 2026
pulisher
Jan 12, 2026

Evnin Luke sells Werewolf Therapeutics (HOWL) shares for $53,533 - Investing.com UK

Jan 12, 2026
pulisher
Jan 12, 2026

Evnin Luke sells Werewolf Therapeutics (HOWL) shares for $53,533 By Investing.com - Investing.com Canada

Jan 12, 2026
pulisher
Jan 10, 2026

Risk Analysis: Will Werewolf Therapeutics Inc. stock benefit from infrastructure spending2025 Technical Patterns & Daily Growth Stock Tips - Улправда

Jan 10, 2026
pulisher
Jan 10, 2026

Is Werewolf Therapeutics Inc. stock ready for breakout2025 Growth vs Value & High Win Rate Trade Tips - ulpravda.ru

Jan 10, 2026
pulisher
Jan 10, 2026

10 Stocks Under $1 That Will Explode - Insider Monkey

Jan 10, 2026
pulisher
Jan 08, 2026

Aug Analyst Calls: Can Werewolf Therapeutics Inc. stock hit analyst price targetsPortfolio Value Summary & Verified Technical Trade Signals - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

How rising interest rates impact Werewolf Therapeutics Inc. stockJuly 2025 Opening Moves & Technical Analysis for Trade Confirmation - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Evnin Luke sells Werewolf Therapeutics (HOWL) stock for $45,882 - Investing.com UK

Jan 08, 2026
pulisher
Jan 07, 2026

Evnin Luke sells Werewolf Therapeutics (HOWL) stock for $45,882 By Investing.com - Investing.com Nigeria

Jan 07, 2026
pulisher
Jan 04, 2026

Luke Evnin Sells 34,847 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock - Defense World

Jan 04, 2026
pulisher
Jan 02, 2026

HOWL Stock Price, Forecast & Analysis | WEREWOLF THERAPEUTICS INC (NASDAQ:HOWL) - Chartmill

Jan 02, 2026
pulisher
Dec 31, 2025

Werewolf Therapeutics stock falls after announcing 64% workforce reduction By Investing.com - Investing.com Canada

Dec 31, 2025
pulisher
Dec 29, 2025

Will Werewolf Therapeutics Inc. stock return to pre crisis levelsAnalyst Upgrades & Capital Efficiency Improvement - bollywoodhelpline.com

Dec 29, 2025
pulisher
Dec 29, 2025

Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Receives Consensus Rating of “Hold” from Analysts - Defense World

Dec 29, 2025

Finanzdaten der Werewolf Therapeutics Inc-Aktie (HOWL)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$26.45
price down icon 1.12%
$45.19
price up icon 0.87%
$101.10
price up icon 0.35%
$105.87
price up icon 0.10%
$148.75
price up icon 1.77%
biotechnology ONC
$346.07
price down icon 0.10%
Kapitalisierung:     |  Volumen (24h):